Legal & General Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-113,294
| Closed | -$4.46M | – | 3451 |
|
|
2023
Q2 | $4.46M | Sell |
113,294
-8,374
| -7% | -$296K | ﹤0.01% | 1519 |
|
|
2023
Q1 | $2.96M | Buy |
121,668
+69,478
| +133% | +$1.52M | ﹤0.01% | 1690 |
|
|
2022
Q4 | $1.12M | Buy |
52,190
+15,336
| +42% | +$327K | ﹤0.01% | 2125 |
|
|
2022
Q3 | $661K | Buy |
36,854
+2,449
| +7% | +$32.1K | ﹤0.01% | 2267 |
|
|
2022
Q2 | $331K | Buy |
34,405
+4,591
| +15% | +$57.6K | ﹤0.01% | 2459 |
|
|
2022
Q1 | $502K | Buy |
29,814
+1,716
| +6% | +$25.4K | ﹤0.01% | 2397 |
|
|
2021
Q4 | $470K | Buy |
28,098
+1,887
| +7% | +$30.9K | ﹤0.01% | 2432 |
|
|
2021
Q3 | $426K | Buy |
26,211
+14,258
| +119% | +$155K | ﹤0.01% | 2464 |
|
|
2021
Q2 | $75K | Buy |
11,953
+891
| +8% | +$5.75K | ﹤0.01% | 2822 |
|
|
2021
Q1 | $68K | Hold |
11,062
| – | – | ﹤0.01% | 2736 |
|
|
2020
Q4 | $76K | Buy |
11,062
+4,195
| +61% | +$26.8K | ﹤0.01% | 2664 |
|
|
2020
Q3 | $39K | Buy |
6,867
+1,119
| +19% | +$5.34K | ﹤0.01% | 2775 |
|
|
2020
Q2 | $29K | Buy |
+5,748
| New | +$23.9K | ﹤0.01% | 2918 |
|
|
2017
Q2 | – | Sell |
-7,119
| Closed | -$26K | – | 3398 |
|
|
2017
Q1 | $26K | Sell |
7,119
-4,883
| -41% | -$20.6K | ﹤0.01% | 3020 |
|
|
2016
Q4 | $58K | Buy |
12,002
+4,615
| +62% | +$137K | ﹤0.01% | 2845 |
|
|
2016
Q3 | $341K | Sell |
7,387
-664
| -8% | -$37.4K | ﹤0.01% | 1874 |
|
|
2016
Q2 | $410K | Buy |
8,051
+2,775
| +53% | +$138K | ﹤0.01% | 1428 |
|
|
2016
Q1 | $220K | Sell |
5,276
-217
| -4% | -$11.1K | ﹤0.01% | 1706 |
|
|
2015
Q4 | $426K | Hold |
5,493
| – | – | ﹤0.01% | 1379 |
|
|
2015
Q3 | $211K | Buy |
5,493
+1,795
| +49% | +$95.1K | ﹤0.01% | 1672 |
|
|
2015
Q2 | $188K | Buy |
3,698
+1,633
| +79% | +$81.2K | ﹤0.01% | 1776 |
|
|
2015
Q1 | $99K | Hold |
2,065
| – | – | ﹤0.01% | 2053 |
|
|
2014
Q4 | $93K | Hold |
2,065
| – | – | ﹤0.01% | 2025 |
|
|
2014
Q3 | $79K | Buy |
+2,065
| New | +$81K | ﹤0.01% | 2074 |
|
Legal & General Group's ISEE Position: Q3 2023 in Review
Legal & General Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 113,294 shares — an estimated $4.46M sold.
Legal & General Group first reported a position in ISEE in Q3 2014 and held it in 24 quarters. The position peaked at $4.46M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Legal & General Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Legal & General Group sold 113,294 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $4.46M.
- Legal & General Group first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 24 quarters.
- Legal & General Group's IVERIC bio, Inc. Common Stock position peaked at $4.46M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Legal & General Group's 13F filing for Q3 2023, filed 14 Nov 2023.